The Path to Patient Centricity: Part IV
Learn more from Regina Shanklin on how maximizing engagement with your audience and patients will help increase the relevance of your brand communications
The Path to Patient Centricity: Part III
Learn more from Regina Shanklin on how being useful to your audience and patients will help increase the relevance of your brand communications
The Path to Patient Centricity: Part II
Learn more from Regina Shanklin on how being completely understandable to your audience will help increase the relevance of your brand communications
The Path to Patient Centricity: Part I
Learn more from Regina Shanklin on how seeing things from the patient’s point-of-view will help you meet them where they are and increase the relevance of your brand communications
Igniting Innovation Through Deep Empathy
Igniting Innovation Through Deep Empathy– Part 2: Five Ways to Achieve Deep Empathy
Design-thinking in innovation is essential to creating the passionate buyers that will flock to buy your product or service and remain loyal over time.
Igniting Innovation through Deep Empathy: Part 1-The Design Thinking Model
Leveraging the Evolving Regulatory Landscape to Accelerate Drug & Medical Devices Development
The Food & Drug Administration has actively engaged in efforts to issue new regulations and guidance aimed at driving innovation, reducing risk, and improving patient safety.
YourEncore Life Sciences Overview - Consulting
YourEncore Capabilities - Virtual Development Deck
[WEBINAR] State of the Industry Webinar: U.S. Regulatory Policy Improvements
Welcome to the Real World: A Reality Check for Digital Health with Dr. Ron Razmi (Ep. 17 of The Pharmcast)
This week on The Pharmcast, we tackle one of the hottest topics in the life sciences and healthcare industry: digital health. The promise of digital health is enticing, and a...
Health & Wellness: Patients as Consumers Driving Change
The face of healthcare is undergoing major changes. Traditional relationships between healthcare providers, payers and patients are being turned on their head. This revolution is being...
FDA 483 Responses: Avoiding Common Pitfalls and Deficiencies (Ep. 8 on The Pharmcast)
This week on The Pharmcast, we explore best practices and common pitfalls in FDA 483 Responses. In 2015, there were an average of 175 inspections and 10 warning letters issued per...
[WEBINAR] Knowledge Management: How to Capture, Retain, & Leverage Expertise Before It Walks Out the Door
FSMA Implementation: 3 Lessons Learned Along the Way
Over the course of my 36 years with The Hershey Company, I helped lead and execute a number of global Quality, Regulatory, and Governance initiatives. Perhaps one of the most...
FSMA Compliance: 4 Steps to Move Forward with Confidence
The time is now, yet the journey is still just beginning. Since January 2011, significant work has been underway by both food regulators and the regulated industries preparing for...
5 Visual Communication Tools that Build Brands
When you hear the term “product demonstration,” you typically think of a TV commercial showing how your product delivers its brand promise. Over the past 38 years, I’ve created hundreds...
[WEBINAR] A Picture is Worth 1,000 Words: Developing Powerful Product Demonstrations to Help Brands Grow
Effective product demonstrations and claim visualizations can differentiate CPG brands and drive growth - if done well. If done poorly, you can find yourself under fire from competitors and consumer
Getting Real World About Outcomes Data